Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279597
What this trial is testing
A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer
Who this might be right for
Muscle-invasive Bladder Urothelial Carcinoma
Tongji Hospital 45